Anti-CD19 CAR-T cell therapy

CD19-targeted chimeric antigen receptor T cells

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Anti-CD19 CAR-T cell therapy, covering 2016-08-03 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy [Phase 2]